Effectiveness Evaluation of a Mobile Application for Rheumatoid Arthritis

Launched by KIRIKKALE UNIVERSITY · Mar 7, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new mobile application designed to help people with rheumatoid arthritis (RA). The goal is to see if using this app can improve the quality of life for patients and help reduce their disease activity, which refers to how much their RA is affecting them. Participants in the study will be divided into two groups: one group will use the app for 12 weeks, while the other group will continue with their usual care. After the study, the second group will also get access to the app.

To join the study, participants need to be at least 18 years old and have a diagnosis of rheumatoid arthritis. They should have been on stable treatment for the last three months and must have a personal smartphone with internet access. It’s important that participants can read and write in Turkish and are willing to use the app regularly throughout the study. Some people may not be eligible, such as those who are pregnant or have certain other health conditions. Overall, this trial aims to explore how technology might support better management of rheumatoid arthritis for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Be 18 years of age or older
• • Diagnosis of Rheumatoid Arthritis according to the American College of Rheumatology (ACR) 1987 criteria
• • Receiving stable treatment for the last 3 months with no new treatments added at the last check-up
• • Ability to read and write in Turkish
• • Ownership of a personal smartphone with internet connectivity and the ability to use an application
• • Willingness to participate in the study
• Exclusion Criteria:
• • Pregnancy or breastfeeding
• • Having a diagnosis of inflammatory diseases or a disease that may significantly affect the functional status (such as Multiple Sclerosis, stroke, Systemic Lupus Erythematosus, Ankylosing Spondylitis, Psoriatic Arthritis)
• • Not having any neurological or psychiatric disease/problem diagnosed by a physician
• • Wanting to withdraw from the study
• • Exiting during the study process
• • Not logging in to the mobile application once a week during the study implementation period (twelve weeks) for the intervention group